Controls (n = 53) | CKD 3–5 patients (n = 257) | P value | |
---|---|---|---|
Age, years | 6012 | 5512 | <0.05 |
Gender, male % | 68 | 64 | nsa |
Diabetes,% | 4 | 34 | <0.001 |
CVD, % | 9 | 35 | <0.001 |
GFR mL/min/1.73 m2 | 85 (58–118) | 7.3 (0.8–52.0) | <0.001 |
CRPb mg/L | 1.2 (0.2–32.0) | 4.2 (0.2–218.0) | <0.05 |
IL-6,b pg/mL | 2.2 (0.4–10.0) | 4.3 (0.7–48.4) | <0.05 |
Cholesterol,c mmol/L | 5.2 ± 0.8 | 5.2 ±1.3 | nsa |
Triglycerides,c mmol/L | 1.4 ± 0.7 | 2.1 ±1.3 | <0.001 |
BMI,c kg/m2 | 26.1 ± 4.2 | 24.9 ± 4.6 | <0.05 |
Albumin,c g/L | 39 ± 3 | 33 ± 6 | <0.05 |
Apo A-I,c g/L | 1.5 ± 0.3 | 1.4 ± 0.3 | 0.006 |
Apo B,c g/L | 0.97 ± 0.21 | 1.02 ± 0.32 | nsa |
Apo B/apo A-I ratioc | 0.68 ± 0.20 | 0.81 ± 0.34 | 0.02 |